CSPG4: Difference between revisions
Jump to navigation
Jump to search
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}) |
m Bot: HTTP→HTTPS |
||
Line 1: | Line 1: | ||
{{Infobox_gene}} | |||
{{ | '''Chondroitin sulfate proteoglycan 4''', also known as '''melanoma-associated chondroitin sulfate proteoglycan''' ('''MCSP''') or '''neuron-glial antigen 2''' ('''NG2'''), is a [[chondroitin sulfate proteoglycan]] that in humans is encoded by the ''CSPG4'' [[gene]].<ref name="pmid8790396">{{cite journal | vauthors = Pluschke G, Vanek M, Evans A, Dittmar T, Schmid P, Itin P, Filardo EJ, Reisfeld RA | title = Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan | journal = Proc Natl Acad Sci U S A | volume = 93 | issue = 18 | pages = 9710–5 |date=Oct 1996 | pmid = 8790396 | pmc = 38494 | doi =10.1073/pnas.93.18.9710 }}</ref><ref name="pmid16407841">{{cite journal | vauthors = Luo W, Wang X, Kageshita T, Wakasugi S, Karpf AR, Ferrone S | title = Regulation of high molecular weight-melanoma associated antigen (HMW-MAA) gene expression by promoter DNA methylation in human melanoma cells | journal = Oncogene | volume = 25 | issue = 20 | pages = 2873–84 |date=May 2006 | pmid = 16407841 | pmc = | doi = 10.1038/sj.onc.1209319 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: CSPG4 chondroitin sulfate proteoglycan 4| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=1464| accessdate = }}</ref> | ||
| | |||
| | |||
| | |||
| | |||
| | |||
}} | |||
CSPG4 plays a role in stabilizing cell-substratum interactions during early events of melanoma cell spreading on [[endothelium|endothelial]] [[basement membrane]]s. It represents an integral membrane chondroitin sulfate proteoglycan expressed by human [[melanoma|malignant melanoma]] cells.<ref name="entrez" /> | |||
==See also== | |||
* [[NG2-glia]] | |||
==References== | ==References== | ||
{{reflist | {{reflist}} | ||
==Further reading== | ==Further reading== | ||
{{refbegin | 2}} | {{refbegin | 2}} | ||
*{{cite journal | vauthors=Kirschfink M, Blase L, Engelmann S, Schwartz-Albiez R |title=Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1. |journal=J. Immunol. |volume=158 |issue= 3 |pages= 1324–31 |year= 1997 |pmid= 9013976 |doi= }} | |||
*{{cite journal | vauthors=Iida J, Meijne AM, Oegema TR |title=A role of chondroitin sulfate glycosaminoglycan binding site in alpha4beta1 integrin-mediated melanoma cell adhesion. |journal=J. Biol. Chem. |volume=273 |issue= 10 |pages= 5955–62 |year= 1998 |pmid= 9488735 |doi=10.1074/jbc.273.10.5955 |display-authors=etal}} | |||
*{{cite journal | | *{{cite journal | vauthors=Eisenmann KM, McCarthy JB, Simpson MA |title=Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas. |journal=Nat. Cell Biol. |volume=1 |issue= 8 |pages= 507–13 |year= 2000 |pmid= 10587647 |doi= 10.1038/70302 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Barritt DS, Pearn MT, Zisch AH |title=The multi-PDZ domain protein MUPP1 is a cytoplasmic ligand for the membrane-spanning proteoglycan NG2. |journal=J. Cell. Biochem. |volume=79 |issue= 2 |pages= 213–24 |year= 2000 |pmid= 10967549 |doi=10.1002/1097-4644(20001101)79:2<213::AID-JCB50>3.0.CO;2-G |pmc=3501957|display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Iida J, Pei D, Kang T |title=Melanoma chondroitin sulfate proteoglycan regulates matrix metalloproteinase-dependent human melanoma invasion into type I collagen. |journal=J. Biol. Chem. |volume=276 |issue= 22 |pages= 18786–94 |year= 2001 |pmid= 11278606 |doi= 10.1074/jbc.M010053200 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Staub E, Hinzmann B, Rosenthal A |title=A novel repeat in the melanoma-associated chondroitin sulfate proteoglycan defines a new protein family. |journal=FEBS Lett. |volume=527 |issue= 1-3 |pages= 114–8 |year= 2002 |pmid= 12220645 |doi=10.1016/S0014-5793(02)03195-2 }} | ||
*{{cite journal | vauthors=Stegmüller J, Werner H, Nave KA, Trotter J |title=The proteoglycan NG2 is complexed with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by the PDZ glutamate receptor interaction protein (GRIP) in glial progenitor cells. Implications for glial-neuronal signaling. |journal=J. Biol. Chem. |volume=278 |issue= 6 |pages= 3590–8 |year= 2003 |pmid= 12458226 |doi= 10.1074/jbc.M210010200 }} | |||
*{{cite journal | | *{{cite journal | vauthors=Strausberg RL, Feingold EA, Grouse LH |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Legg J, Jensen UB, Broad S |title=Role of melanoma chondroitin sulphate proteoglycan in patterning stem cells in human interfollicular epidermis. |journal=Development |volume=130 |issue= 24 |pages= 6049–63 |year= 2004 |pmid= 14573520 |doi= 10.1242/dev.00837 |display-authors=etal}} | ||
*{{cite journal | vauthors=Ghali L, Wong ST, Tidman N |title=Epidermal and hair follicle progenitor cells express melanoma-associated chondroitin sulfate proteoglycan core protein. |journal=J. Invest. Dermatol. |volume=122 |issue= 2 |pages= 433–42 |year= 2004 |pmid= 15009727 |doi= 10.1046/j.0022-202X.2004.22207.x |display-authors=etal}} | |||
*{{cite journal | | *{{cite journal | vauthors=Fukushi J, Makagiansar IT, Stallcup WB |title=NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin. |journal=Mol. Biol. Cell |volume=15 |issue= 8 |pages= 3580–90 |year= 2005 |pmid= 15181153 |doi= 10.1091/mbc.E04-03-0236 | pmc=491820 }} | ||
*{{cite journal | | *{{cite journal | vauthors=Yang J, Price MA, Neudauer CL |title=Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms. |journal=J. Cell Biol. |volume=165 |issue= 6 |pages= 881–91 |year= 2004 |pmid= 15210734 |doi= 10.1083/jcb.200403174 | pmc=2172406 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Colland F, Jacq X, Trouplin V |title=Functional proteomics mapping of a human signaling pathway. |journal=Genome Res. |volume=14 |issue= 7 |pages= 1324–32 |year= 2004 |pmid= 15231748 |doi= 10.1101/gr.2334104 | pmc=442148 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Suzuki Y, Yamashita R, Shirota M |title=Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions. |journal=Genome Res. |volume=14 |issue= 9 |pages= 1711–8 |year= 2004 |pmid= 15342556 |doi= 10.1101/gr.2435604 | pmc=515316 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Makagiansar IT, Williams S, Dahlin-Huppe K |title=Phosphorylation of NG2 proteoglycan by protein kinase C-alpha regulates polarized membrane distribution and cell motility. |journal=J. Biol. Chem. |volume=279 |issue= 53 |pages= 55262–70 |year= 2005 |pmid= 15504744 |doi= 10.1074/jbc.M411045200 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Petrini S, Tessa A, Stallcup WB |title=Altered expression of the MCSP/NG2 chondroitin sulfate proteoglycan in collagen VI deficiency. |journal=Mol. Cell. Neurosci. |volume=30 |issue= 3 |pages= 408–17 |year= 2006 |pmid= 16169245 |doi= 10.1016/j.mcn.2005.08.005 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Brekke C, Lundervold A, Enger PØ |title=NG2 expression regulates vascular morphology and function in human brain tumours. |journal=NeuroImage |volume=29 |issue= 3 |pages= 965–76 |year= 2006 |pmid= 16253523 |doi= 10.1016/j.neuroimage.2005.08.026 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Liu T, Qian WJ, Gritsenko MA |title=Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. |journal=J. Proteome Res. |volume=4 |issue= 6 |pages= 2070–80 |year= 2006 |pmid= 16335952 |doi= 10.1021/pr0502065 | pmc=1850943 |display-authors=etal}} | ||
*{{cite journal | | |||
*{{cite journal | | |||
}} | |||
{{refend}} | {{refend}} | ||
{{ | ==External links== | ||
{{ | * {{UCSC gene info|CSPG4}} | ||
{{proteoglycans}} | |||
{{gene-15-stub}} |
Revision as of 10:06, 30 August 2017
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Chondroitin sulfate proteoglycan 4, also known as melanoma-associated chondroitin sulfate proteoglycan (MCSP) or neuron-glial antigen 2 (NG2), is a chondroitin sulfate proteoglycan that in humans is encoded by the CSPG4 gene.[1][2][3]
CSPG4 plays a role in stabilizing cell-substratum interactions during early events of melanoma cell spreading on endothelial basement membranes. It represents an integral membrane chondroitin sulfate proteoglycan expressed by human malignant melanoma cells.[3]
See also
References
- ↑ Pluschke G, Vanek M, Evans A, Dittmar T, Schmid P, Itin P, Filardo EJ, Reisfeld RA (Oct 1996). "Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan". Proc Natl Acad Sci U S A. 93 (18): 9710–5. doi:10.1073/pnas.93.18.9710. PMC 38494. PMID 8790396.
- ↑ Luo W, Wang X, Kageshita T, Wakasugi S, Karpf AR, Ferrone S (May 2006). "Regulation of high molecular weight-melanoma associated antigen (HMW-MAA) gene expression by promoter DNA methylation in human melanoma cells". Oncogene. 25 (20): 2873–84. doi:10.1038/sj.onc.1209319. PMID 16407841.
- ↑ 3.0 3.1 "Entrez Gene: CSPG4 chondroitin sulfate proteoglycan 4".
Further reading
- Kirschfink M, Blase L, Engelmann S, Schwartz-Albiez R (1997). "Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1". J. Immunol. 158 (3): 1324–31. PMID 9013976.
- Iida J, Meijne AM, Oegema TR, et al. (1998). "A role of chondroitin sulfate glycosaminoglycan binding site in alpha4beta1 integrin-mediated melanoma cell adhesion". J. Biol. Chem. 273 (10): 5955–62. doi:10.1074/jbc.273.10.5955. PMID 9488735.
- Eisenmann KM, McCarthy JB, Simpson MA, et al. (2000). "Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas". Nat. Cell Biol. 1 (8): 507–13. doi:10.1038/70302. PMID 10587647.
- Barritt DS, Pearn MT, Zisch AH, et al. (2000). "The multi-PDZ domain protein MUPP1 is a cytoplasmic ligand for the membrane-spanning proteoglycan NG2". J. Cell. Biochem. 79 (2): 213–24. doi:10.1002/1097-4644(20001101)79:2<213::AID-JCB50>3.0.CO;2-G. PMC 3501957. PMID 10967549.
- Iida J, Pei D, Kang T, et al. (2001). "Melanoma chondroitin sulfate proteoglycan regulates matrix metalloproteinase-dependent human melanoma invasion into type I collagen". J. Biol. Chem. 276 (22): 18786–94. doi:10.1074/jbc.M010053200. PMID 11278606.
- Staub E, Hinzmann B, Rosenthal A (2002). "A novel repeat in the melanoma-associated chondroitin sulfate proteoglycan defines a new protein family". FEBS Lett. 527 (1–3): 114–8. doi:10.1016/S0014-5793(02)03195-2. PMID 12220645.
- Stegmüller J, Werner H, Nave KA, Trotter J (2003). "The proteoglycan NG2 is complexed with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by the PDZ glutamate receptor interaction protein (GRIP) in glial progenitor cells. Implications for glial-neuronal signaling". J. Biol. Chem. 278 (6): 3590–8. doi:10.1074/jbc.M210010200. PMID 12458226.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Legg J, Jensen UB, Broad S, et al. (2004). "Role of melanoma chondroitin sulphate proteoglycan in patterning stem cells in human interfollicular epidermis". Development. 130 (24): 6049–63. doi:10.1242/dev.00837. PMID 14573520.
- Ghali L, Wong ST, Tidman N, et al. (2004). "Epidermal and hair follicle progenitor cells express melanoma-associated chondroitin sulfate proteoglycan core protein". J. Invest. Dermatol. 122 (2): 433–42. doi:10.1046/j.0022-202X.2004.22207.x. PMID 15009727.
- Fukushi J, Makagiansar IT, Stallcup WB (2005). "NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin". Mol. Biol. Cell. 15 (8): 3580–90. doi:10.1091/mbc.E04-03-0236. PMC 491820. PMID 15181153.
- Yang J, Price MA, Neudauer CL, et al. (2004). "Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms". J. Cell Biol. 165 (6): 881–91. doi:10.1083/jcb.200403174. PMC 2172406. PMID 15210734.
- Colland F, Jacq X, Trouplin V, et al. (2004). "Functional proteomics mapping of a human signaling pathway". Genome Res. 14 (7): 1324–32. doi:10.1101/gr.2334104. PMC 442148. PMID 15231748.
- Suzuki Y, Yamashita R, Shirota M, et al. (2004). "Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions". Genome Res. 14 (9): 1711–8. doi:10.1101/gr.2435604. PMC 515316. PMID 15342556.
- Makagiansar IT, Williams S, Dahlin-Huppe K, et al. (2005). "Phosphorylation of NG2 proteoglycan by protein kinase C-alpha regulates polarized membrane distribution and cell motility". J. Biol. Chem. 279 (53): 55262–70. doi:10.1074/jbc.M411045200. PMID 15504744.
- Petrini S, Tessa A, Stallcup WB, et al. (2006). "Altered expression of the MCSP/NG2 chondroitin sulfate proteoglycan in collagen VI deficiency". Mol. Cell. Neurosci. 30 (3): 408–17. doi:10.1016/j.mcn.2005.08.005. PMID 16169245.
- Brekke C, Lundervold A, Enger PØ, et al. (2006). "NG2 expression regulates vascular morphology and function in human brain tumours". NeuroImage. 29 (3): 965–76. doi:10.1016/j.neuroimage.2005.08.026. PMID 16253523.
- Liu T, Qian WJ, Gritsenko MA, et al. (2006). "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry". J. Proteome Res. 4 (6): 2070–80. doi:10.1021/pr0502065. PMC 1850943. PMID 16335952.
External links
- Human CSPG4 genome location and CSPG4 gene details page in the UCSC Genome Browser.
This article on a gene on human chromosome 15 is a stub. You can help Wikipedia by expanding it. |